Year |
Citation |
Score |
2020 |
Court CM, Hou S, Liu L, Winograd P, DiPardo BJ, Liu SX, Chen PJ, Zhu Y, Smalley M, Zhang R, Sadeghi S, Finn RS, Kaldas FM, Busuttil RW, Zhou XJ, ... Tseng HR, et al. Somatic copy number profiling from hepatocellular carcinoma circulating tumor cells. Npj Precision Oncology. 4: 16. PMID 32637655 DOI: 10.1200/Jco.2018.36.4_Suppl.290 |
0.355 |
|
2020 |
Wang J, Sun N, Lee YT, Ni Y, Koochekpour R, Zhu Y, Tseng HR, Wang S, Jiang L, Zhu H. A circulating tumor cell-based digital assay for the detection of EGFR T790M mutation in advanced non-small cell lung cancer. Journal of Materials Chemistry. B. PMID 32525199 DOI: 10.1039/D0Tb00589D |
0.34 |
|
2020 |
Ahn JC, Teng PC, Chen PJ, Posadas E, Tseng HR, Lu SC, Yang JD. Detection of circulating tumor cells and their implications as a novel biomarker for diagnosis, prognostication, and therapeutic monitoring in hepatocellular carcinoma. Hepatology (Baltimore, Md.). PMID 32017145 DOI: 10.1002/Hep.31165 |
0.363 |
|
2020 |
Teng P, Jan YJ, Chen J, Kim M, Yao N, Garraway I, Chu GC, Chen P, Wang JJ, Lee Y, Zhu Y, Chung LW, Feng FY, Freeman M, You S, ... Tseng H, et al. Prostate cancer CTC-RNA Assay: A new method for contemporary genomics and precision medicine via liquid biopsy. Journal of Clinical Oncology. 38: 170-170. DOI: 10.1200/Jco.2020.38.6_Suppl.170 |
0.317 |
|
2020 |
Wang JJ, Teng P, Jan YJ, Chen J, Cook-Wiens G, Yao N, Chu GC, Chen P, Ho H, Yang Y, Lee Y, Huang J, Chung LW, You S, Zhu Y, ... ... Tseng H, et al. Association of very small nuclear circulating tumor cell (vsnCTC) with clinical outcomes in metastatic castration-resistant prostate cancer. Journal of Clinical Oncology. 38: 168-168. DOI: 10.1200/Jco.2020.38.6_Suppl.168 |
0.404 |
|
2020 |
Wang JJ, Teng P, Jan YJ, Chen J, Cook-Wiens G, Yao N, Chu GC, Chen P, Ho H, Lee Y, Huang J, Li K, Chung LW, Zhu Y, Freeman M, ... ... Tseng H, et al. Circulating tumor cells with small nuclear size: A novel biomarker for survival and clinical outcomes in advanced prostate cancer. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E17512 |
0.416 |
|
2020 |
Teng P, Jan YJ, Kim M, Chen J, Yoon J, Wang JJ, Chen P, Yao N, Lee Y, Lozano A, Gadilov R, Freeman M, You S, Tseng H, Posadas EM. Development of a circulating tumor cell-based RNA classifier for patients with castration-resistant prostate cancer: CTC-PCS/PAM50. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E17509 |
0.382 |
|
2020 |
Wang JJ, Teng P, Jan YJ, Chen J, Cook-Wiens G, Yao N, Chu GC, Chen P, Yang Y, Yeo YH, Lee Y, Chung LW, You S, Zhu Y, Freeman MR, ... ... Tseng H, et al. Abstract 4331: Nuclear size of circulating tumor cells is associated with prognosis in metastatic, castration-resistant prostate cancer Endocrinology. DOI: 10.1158/1538-7445.Am2020-4331 |
0.384 |
|
2020 |
Dong J, Chen J, Smalley M, Zhao M, Ke Z, Zhu Y, Tseng H. Circulating Rare Cells: Nanostructured Substrates for Detection and Characterization of Circulating Rare Cells: From Materials Research to Clinical Applications (Adv. Mater. 1/2020) Advanced Materials. 32: 2070008. DOI: 10.1002/Adma.202070008 |
0.325 |
|
2019 |
Dong J, Chen JF, Smalley M, Zhao M, Ke Z, Zhu Y, Tseng HR. Nanostructured Substrates for Detection and Characterization of Circulating Rare Cells: From Materials Research to Clinical Applications. Advanced Materials (Deerfield Beach, Fla.). e1903663. PMID 31566837 DOI: 10.1002/Adma.201903663 |
0.422 |
|
2019 |
Dong J, Jan YJ, Cheng J, Zhang RY, Meng M, Smalley M, Chen PJ, Tang X, Tseng P, Bao L, Huang TY, Zhou D, Liu Y, Chai X, Zhang H, ... ... Tseng HR, et al. Covalent chemistry on nanostructured substrates enables noninvasive quantification of gene rearrangements in circulating tumor cells. Science Advances. 5: eaav9186. PMID 31392269 DOI: 10.1126/Sciadv.Aav9186 |
0.425 |
|
2019 |
Dong J, Zhang RY, Sun N, Smalley MD, Wu Z, Zhou A, Chou S, Jan YJA, Yang P, Bao L, Qi D, Tang X, Tseng P, Hua Y, Xu D, ... ... Tseng HR, et al. Bio-Inspired NanoVilli Chips for Enhanced Capture of Tumor-Derived Extracellular Vesicles: Toward Non-Invasive Detection of Gene Alterations in Non-Small Cell Lung Cancer. Acs Applied Materials & Interfaces. PMID 30892008 DOI: 10.1021/Acsami.9B01406 |
0.425 |
|
2019 |
Chen P, Jan YJ, Teng P, Chen J, Cheng S, Yao N, Reis-Sobreiro M, Lozano A, Gomez A, Freeman M, Tseng H, Posadas EM. A noninvasive prognostic biomarker for metastatic castration-resistant prostate cancer: Very small nuclear circulating tumor cells. Journal of Clinical Oncology. 37: 179-179. DOI: 10.1200/Jco.2019.37.7_Suppl.179 |
0.394 |
|
2019 |
Jan YJ, Yoon J, Chen J, Chen P, Teng P, Yao N, Cheng S, Lozano A, Freeman M, You S, Tseng H, Posadas EM. A circulating tumor cell RNA assay for dynamic assessment of androgen receptor signaling inhibitors sensitivity in metastatic castration-resistant prostate cancer. Journal of Clinical Oncology. 37: 157-157. DOI: 10.1200/Jco.2019.37.7_Suppl.157 |
0.373 |
|
2019 |
Teng P, Jan YJ, Yoon J, Chen P, Chen J, Yao N, Cheng S, Lozano A, Freeman M, You S, Tseng H, Posadas EM. A circulating tumor cell specific RNA assay for assessment of androgen receptor signaling inhibitor sensitivity in metastatic castration-resistant prostate cancer. Journal of Clinical Oncology. 37: 5059-5059. DOI: 10.1200/Jco.2019.37.15_Suppl.5059 |
0.352 |
|
2019 |
Chen P, Jan YJ, Teng P, Chen J, Cheng S, Yao N, Reis-Sobreiro M, Lozano A, Gomez A, Tseng H, Freeman M, Posadas E. Abstract 436: Prediction of aggressive disease in metastatic castration-resistant prostate cancer: The role of very small nuclear circulating tumor cells Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-436 |
0.372 |
|
2019 |
Teng P, Jan YJ, Yoon J, Chen J, Chen P, Yao N, Cheng S, Lozano A, Freeman MR, You S, Tseng H, Posadas EM. Abstract 453: A circulating tumor cell assay for dynamic assessment of drug sensitivity in metastatic castration-resistant prostate cancer Cancer Research. 79: 453-453. DOI: 10.1158/1538-7445.Am2019-453 |
0.394 |
|
2019 |
Chen P, Teng P, Zhu Y, Jan YJ, Smalley M, Afshar Y, Chen L, Pisarska MD, Tseng H. Noninvasive Prenatal Diagnostics: Recent Developments Using Circulating Fetal Nucleated Cells Current Obstetrics and Gynecology Reports. 8: 1-8. DOI: 10.1007/S13669-019-0254-X |
0.309 |
|
2018 |
Reis-Sobreiro M, Chen JF, Novitskaya T, You S, Morley S, Steadman K, Kaur Gill N, Eskaros A, Rotinen M, Chu CY, Chung LWK, Tanaka H, Yang W, Knudsen BS, Tseng HR, et al. Emerin deregulation links nuclear shape instability to metastatic potential. Cancer Research. PMID 30154147 DOI: 10.1158/0008-5472.Can-18-0608 |
0.36 |
|
2018 |
Yao N, Jan YJ, Cheng S, Chen JF, Chung LW, Tseng HR, Posadas EM. Structure and function analysis in circulating tumor cells: using nanotechnology to study nuclear size in prostate cancer. American Journal of Clinical and Experimental Urology. 6: 43-54. PMID 29666832 |
0.307 |
|
2018 |
Court CM, Hou S, Winograd P, Segel NH, Li QW, Zhu Y, Sadeghi S, Finn RS, Ganapathy E, Song M, French SW, Naini BV, Sho S, Kaldas FM, Busuttil RW, ... ... Tseng HR, et al. A Novel Multimarker Assay for the Phenotypic Profiling of Circulating Tumor Cells in Hepatocellular Carcinoma. Liver Transplantation : Official Publication of the American Association For the Study of Liver Diseases and the International Liver Transplantation Society. PMID 29624843 DOI: 10.1002/Lt.25062 |
0.322 |
|
2018 |
Jan YJ, Chen JF, Zhu Y, Lu YT, Chen SH, Chung H, Smalley M, Huang YW, Dong J, Yu HH, Tomlinson JS, Hou S, Agopian VG, Posadas EM, Tseng HR. NanoVelcro rare-cell assays for detection and characterization of circulating tumor cells. Advanced Drug Delivery Reviews. PMID 29551650 DOI: 10.1016/J.Addr.2018.03.006 |
0.472 |
|
2018 |
Xu X, Hou S, Wattanatorn N, Wang F, Yang Q, Zhao C, Yu X, Tseng HR, Jonas SJ, Weiss PS. Precision-Guided Nanospears for Targeted and High-Throughput Intracellular Gene Delivery. Acs Nano. PMID 29536729 DOI: 10.1021/Acsnano.8B00763 |
0.309 |
|
2018 |
Salem AF, Wang S, Billet S, Chen JF, Udompholkul P, Gambini L, Baggio C, Tseng HR, Posadas EM, Bhowmick NA, Pellecchia M. A potent EphA2 agonistic peptide-drug conjugate reduces circulating cancer cells and metastases in breast cancer models. Journal of Medicinal Chemistry. PMID 29470068 DOI: 10.1021/Acs.Jmedchem.7B01837 |
0.337 |
|
2018 |
Court CM, Ankeny JS, Sho S, Winograd P, Hou S, Song M, Wainberg ZA, Girgis MD, Graeber TG, Agopian VG, Tseng HR, Tomlinson JS. Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer. Annals of Surgical Oncology. PMID 29442211 DOI: 10.1245/S10434-017-6290-8 |
0.385 |
|
2018 |
Jan YJ, Chen J, You S, Yao N, Cheng S, Freeman M, Tseng H, Posadas EM. NanoVelcro CTC purification systems for expressional analysis of circulating tumor cells from prostate cancer patients. Journal of Clinical Oncology. 36: 295-295. DOI: 10.1200/Jco.2018.36.6_Suppl.295 |
0.424 |
|
2018 |
Jan YJ, You S, Yoon J, Chen J, Yao N, Cheng S, Freeman M, Tseng H, Posadas EM. Dynamic variations in gene expressions of circulating tumor cells in metastatic castration-resistant prostate cancer patients in response to androgen receptor signaling inhibitors. Journal of Clinical Oncology. 36: e17063-e17063. DOI: 10.1200/Jco.2018.36.15_Suppl.E17063 |
0.345 |
|
2018 |
Jan YJ, Chen J, You S, Yoon J, Yao N, Cheng S, Freeman MR, Tseng H, Posadas EM. Abstract 1578: NanoVelcro CTC Purification Systems for expressional analysis of circulating tumor cells from prostate cancer patients Cancer Research. 78: 1578-1578. DOI: 10.1158/1538-7445.Am2018-1578 |
0.415 |
|
2018 |
Shen M, Chen J, Luo C, Lee S, Li C, Yang Y, Tsai Y, Ho B, Bao L, Lee T, Jan YJ, Zhu Y, Cheng S, Feng FY, Chen P, ... ... Tseng H, et al. RNA Biomarkers: Glycan Stimulation Enables Purification of Prostate Cancer Circulating Tumor Cells on PEDOT NanoVelcro Chips for RNA Biomarker Detection (Adv. Healthcare Mater. 3/2018) Advanced Healthcare Materials. 7: 1870013. DOI: 10.1002/Adhm.201870013 |
0.356 |
|
2017 |
Shen MY, Chen JF, Luo CH, Lee S, Li CH, Yang YL, Tsai YH, Ho BC, Bao LR, Lee TJ, Jan YJ, Zhu YZ, Cheng S, Feng FY, Chen P, ... ... Tseng HR, et al. Glycan Stimulation Enables Purification of Prostate Cancer Circulating Tumor Cells on PEDOT NanoVelcro Chips for RNA Biomarker Detection. Advanced Healthcare Materials. PMID 28892262 DOI: 10.1002/Adhm.201700701 |
0.421 |
|
2017 |
Hou S, Chen JF, Song M, Zhu Y, Jan YJ, Chen SH, Weng TH, Ling DA, Chen SF, Ro T, Liang AJ, Lee T, Jin H, Li M, Liu L, ... ... Tseng HR, et al. Imprinted NanoVelcro Microchips for Isolation and Characterization of Circulating Fetal Trophoblasts: toward Noninvasive Prenatal Diagnostics. Acs Nano. PMID 28721719 DOI: 10.1021/Acsnano.7B03073 |
0.309 |
|
2017 |
Sho S, Court CM, Winograd P, Lee S, Hou S, Graeber TG, Tseng HR, Tomlinson JS. Precision oncology using a limited number of cells: optimization of whole genome amplification products for sequencing applications. Bmc Cancer. 17: 457. PMID 28666423 DOI: 10.1186/S12885-017-3447-6 |
0.342 |
|
2017 |
Chen JF, Lu YT, Cheng S, Tseng HR, Figlin RA, Posadas EM. Circulating tumor cells in prostate cancer: beyond enumeration. Clinical Advances in Hematology & Oncology : H&O. 15: 63-73. PMID 28212371 |
0.315 |
|
2017 |
Sho S, Court CM, Kim S, Braxton DR, Hou S, Muthusamy VR, Watson RR, Sedarat A, Tseng HR, Tomlinson JS. Digital PCR Improves Mutation Analysis in Pancreas Fine Needle Aspiration Biopsy Specimens. Plos One. 12: e0170897. PMID 28125707 DOI: 10.1371/Journal.Pone.0170897 |
0.378 |
|
2017 |
Posadas EM, Chen J, Tripathi M, Lu Y, Montes A, Go A, Ureno A, Cavassani KA, Sievert M, Rogatko A, Limvorasak S, Oppenheim A, Moldawer NP, Chung LW, Bhowmick N, ... Tseng H, et al. Circulating tumor cell subsets and macrophage polarization to predict efficacy of cabozantinib in advanced prostate cancer with visceral metastases. Journal of Clinical Oncology. 35: 5031-5031. DOI: 10.1200/Jco.2017.35.15_Suppl.5031 |
0.381 |
|
2017 |
Chen J, Shen M, Luo C, Cheng S, Lee S, Hou S, Posadas EM, Tseng H, Yu H. Abstract 3780: Bio-competition-based smart NanoVelcro Chip for isolation and gene expression analysis of circulating tumor cells from prostate cancer patients Cancer Research. 77: 3780-3780. DOI: 10.1158/1538-7445.Am2017-3780 |
0.436 |
|
2016 |
Cheng S, Chen JF, Lu YT, Chung LWK, Tseng HR, Posadas EM. Applications of circulating tumor cells for prostate cancer. Asian Journal of Urology. 3: 254-259. PMID 29264193 DOI: 10.1016/J.Ajur.2016.09.004 |
0.406 |
|
2016 |
Wang R, Chu GCY, Mrdenovic S, Annamalai AA, Hendifar AE, Nissen NN, Tomlinson JS, Lewis M, Palanisamy N, Tseng HR, Posadas EM, Freeman MR, Pandol SJ, Zhau HE, Chung LWK. Cultured circulating tumor cells and their derived xenografts for personalized oncology. Asian Journal of Urology. 3: 240-253. PMID 29264192 DOI: 10.1016/J.Ajur.2016.08.005 |
0.424 |
|
2016 |
Liu S, Tian Z, Zhang L, Hou S, Hu S, Wu J, Jing Y, Sun H, Yu F, Zhao L, Wang R, Tseng HR, Zhau HE, Chung LW, Wu K, et al. Combined cell surface carbonic anhydrase 9 and CD147 antigens enable high-efficiency capture of circulating tumor cells in clear cell renal cell carcinoma patients. Oncotarget. PMID 27494883 DOI: 10.18632/Oncotarget.10979 |
0.397 |
|
2016 |
Nair BG, Hagiwara K, Ueda M, Yu HH, Tseng HR, Ito Y. High Density of Aligned Nanowire Treated with Polydopamine for Efficient Gene Silencing by siRNA According to Cell Membrane Perturbation. Acs Applied Materials & Interfaces. PMID 27420034 DOI: 10.1021/Acsami.6B04913 |
0.308 |
|
2016 |
Chen JF, Zhu Y, Lu YT, Hodara E, Hou S, Agopian VG, Tomlinson JS, Posadas EM, Tseng HR. Clinical Applications of NanoVelcro Rare-Cell Assays for Detection and Characterization of Circulating Tumor Cells. Theranostics. 6: 1425-39. PMID 27375790 DOI: 10.7150/Thno.15359 |
0.437 |
|
2016 |
Court CM, Ankeny JS, Sho S, Hou S, Li Q, Hsieh C, Song M, Liao X, Rochefort MM, Wainberg Z, Graeber TG, Tseng HR, Tomlinson JS. Reality of Single Circulating Tumor Cell Sequencing for Molecular Diagnostics in Pancreatic Cancer. The Journal of Molecular Diagnostics : Jmd. PMID 27375074 DOI: 10.1016/J.Jmoldx.2016.03.006 |
0.343 |
|
2016 |
He W, Xu D, Wang Z, Xiang X, Tang B, Li S, Hou M, Zhang Y, Chen JF, Lin M, Wang L, Hou S, Tseng HR, Kuang M, Ke ZF. Detecting ALK-rearrangement of CTC enriched by nanovelcro chip in advanced NSCLC patients. Oncotarget. PMID 27029032 DOI: 10.18632/Oncotarget.8305 |
0.352 |
|
2016 |
Liu Y, Du J, Choi JS, Chen KJ, Hou S, Yan M, Lin WY, Chen KS, Ro T, Lipshutz GS, Wu L, Shi L, Lu Y, Tseng HR, Wang H. A High-Throughput Platform for Formulating and Screening Multifunctional Nanoparticles Capable of Simultaneous Delivery of Genes and Transcription Factors. Angewandte Chemie (International Ed. in English). 55: 169-73. PMID 26768819 DOI: 10.1002/Anie.201507546 |
0.534 |
|
2016 |
Zhao L, Tang C, Xu L, Zhang Z, Li X, Hu H, Cheng S, Zhou W, Huang M, Fong A, Liu B, Tseng HR, Gao H, Liu Y, Fang X. Enhanced and Differential Capture of Circulating Tumor Cells from Lung Cancer Patients by Microfluidic Assays Using Aptamer Cocktail. Small (Weinheim An Der Bergstrasse, Germany). PMID 26763166 DOI: 10.1002/Smll.201503188 |
0.432 |
|
2016 |
Hou S, Choi JS, Garcia MA, Xing Y, Chen KJ, Chen YM, Jiang ZK, Ro T, Wu L, Stout DB, Tomlinson J, Wang H, Chen K, Tseng HR, Lin WY. Pretargeted Positron Emission Tomography Imaging that Employs Supramolecular Nanoparticles with in Vivo Bioorthogonal Chemistry. Acs Nano. PMID 26731174 DOI: 10.1021/Acsnano.5B06860 |
0.677 |
|
2016 |
Chen J, Ho H, Hodara E, Go A, Ureno A, Kaufman ET, Sievert M, Chung LW, Ke Z, Tseng H, Posadas EM. Very small nuclear circulating tumor cell (vsnCTC) as a putative biomarker for visceral metastasis in metastatic castration-resistant prostate cancer (mCRPC). Journal of Clinical Oncology. 34: 64-64. DOI: 10.1200/Jco.2016.34.2_Suppl.64 |
0.372 |
|
2016 |
Huynh R, Chen J, Tighiouart M, Sievert M, Oppenheim A, Moldawer NP, Knudsen B, Freeman M, Bhowmick N, Rogatko A, Tseng H, Chung LW, Scher K, Figlin RA, Posadas EM. A phase II study of cabozantinib in metastatic castration-resistant prostate cancer (mCRPC) with visceral metastases (VM) with very small nuclear circulating tumor cell (vsnCTC) association studies. Journal of Clinical Oncology. 34: 208-208. DOI: 10.1200/Jco.2016.34.2_Suppl.208 |
0.337 |
|
2016 |
Chen J, Ho H, Hodara E, Ureno A, Go A, Kaufman E, Sievert M, Luthringer DJ, Huang J, Chung L, Ke Z, Li K, Tseng H, Posadas EM. Abstract 4962: Very-small-nuclear circulating tumor cell (vsnCTC) as a putative biomarker for visceral metastasis in metastatic castration-resistant prostate cancer (mCRPC) Cancer Research. 76: 4962-4962. DOI: 10.1158/1538-7445.Am2016-4962 |
0.395 |
|
2015 |
Jiang R, Lu YT, Ho H, Li B, Chen JF, Lin M, Li F, Wu K, Wu H, Lichterman J, Wan H, Lu CL, OuYang W, Ni M, Wang L, ... ... Tseng HR, et al. A comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancer. Oncotarget. PMID 26575023 DOI: 10.18632/Oncotarget.6330 |
0.418 |
|
2015 |
Court CM, Ankeny JS, Hou S, Tseng HR, Tomlinson JS. Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis. Expert Review of Molecular Diagnostics. 1-14. PMID 26390158 DOI: 10.1586/14737159.2015.1091311 |
0.416 |
|
2015 |
Chen JF, Ho H, Lichterman J, Lu YT, Zhang Y, Garcia MA, Chen SF, Liang AJ, Hodara E, Zhau HE, Hou S, Ahmed RS, Luthringer DJ, Huang J, Li KC, ... ... Tseng HR, et al. Subclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases. Cancer. PMID 25975562 DOI: 10.1002/Cncr.29455 |
0.644 |
|
2015 |
Hou S, Choi JS, Chen KJ, Zhang Y, Peng J, Garcia MA, Yu JH, Thakore-Shah K, Ro T, Chen JF, Peyda P, Fan G, Pyle AD, Wang H, Tseng HR. Supramolecular nanosubstrate-mediated delivery for reprogramming and transdifferentiation of Mammalian cells. Small (Weinheim An Der Bergstrasse, Germany). 11: 2499-504. PMID 25613059 DOI: 10.1002/Smll.201402602 |
0.655 |
|
2015 |
Ke Z, Lin M, Chen JF, Choi JS, Zhang Y, Fong A, Liang AJ, Chen SF, Li Q, Fang W, Zhang P, Garcia MA, Lee T, Song M, Lin HA, ... ... Tseng HR, et al. Programming thermoresponsiveness of NanoVelcro substrates enables effective purification of circulating tumor cells in lung cancer patients. Acs Nano. 9: 62-70. PMID 25495128 DOI: 10.1021/Nn5056282 |
0.639 |
|
2015 |
Lu Y, Chen J, Ho H, Lichterman J, Chung LW, Li K, Ke Z, Tseng H, Posadas EM. Subclassification of prostate cancer circulating tumor cells (CTCs) by nuclear size reveals very-small nuclear CTCs in patients with visceral metastases. Journal of Clinical Oncology. 33: 11027-11027. DOI: 10.1200/Jco.2015.33.15_Suppl.11027 |
0.391 |
|
2015 |
Chen J, Ho H, Lichterman J, Lu Y, Zhang Y, Garcia MA, Chen S, Liang A, Zhau HE, Hou S, Ahmed RS, Luthringer DJ, Huang J, Li K, Chung LW, ... ... Tseng H, et al. Abstract 3473: Sub-classification of prostate cancer circulating tumor cells (CTCs) by nuclear size reveals very-small nuclear CTCs in patients with visceral metastases Cancer Research. 75: 3473-3473. DOI: 10.1158/1538-7445.Am2015-3473 |
0.638 |
|
2014 |
Posadas EM, Tighiouart M, Lu Y, Di Vizio D, Hoffman D, Green L, Scher K, Sievert M, Oppenheim A, Moldawer N, Knudsen B, Freeman M, Bhowmick N, Rogatko A, Tseng H, et al. 1574PA TRANSLATIONAL PHASE 2 STUDY OF CABOZANTINIB IN MEN WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER WITH VISCERAL METASTASES WITH CHARACTERIZATION OF CIRCULATING TUMOR CELLS AND LARGE ONCOSOMES. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 25: iv547. PMID 28171512 DOI: 10.1093/Annonc/Mdu358.5 |
0.38 |
|
2014 |
Lin M, Chen JF, Lu YT, Zhang Y, Song J, Hou S, Ke Z, Tseng HR. Nanostructure embedded microchips for detection, isolation, and characterization of circulating tumor cells. Accounts of Chemical Research. 47: 2941-50. PMID 25111636 DOI: 10.1021/Ar5001617 |
0.462 |
|
2014 |
Peng J, Garcia MA, Choi JS, Zhao L, Chen KJ, Bernstein JR, Peyda P, Hsiao YS, Liu KW, Lin WY, Pyle AD, Wang H, Hou S, Tseng HR. Molecular recognition enables nanosubstrate-mediated delivery of gene-encapsulated nanoparticles with high efficiency. Acs Nano. 8: 4621-9. PMID 24708312 DOI: 10.1021/Nn5003024 |
0.659 |
|
2014 |
Hsiao YS, Luo SC, Hou S, Zhu B, Sekine J, Kuo CW, Chueh DY, Yu HH, Tseng HR, Chen P. 3D bioelectronic interface: capturing circulating tumor cells onto conducting polymer-based micro/nanorod arrays with chemical and topographical control. Small (Weinheim An Der Bergstrasse, Germany). 10: 3012-7. PMID 24700425 DOI: 10.1002/Smll.201400429 |
0.391 |
|
2014 |
Ankeny JS, Hou S, Lin M, OuYang H, Song M, Rochefort MM, Girgis MD, Isacoff WH, Wainberg ZA, Tseng H, Tomlinson JS. Pancreatic circulating tumor cells as a diagnostic adjunct in pancreatic cancer. Journal of Clinical Oncology. 32: 175-175. DOI: 10.1200/Jco.2014.32.3_Suppl.175 |
0.392 |
|
2014 |
Posadas EM, Tighgohart M, Lu Y, Vizio DD, Hoffman DMJ, Green L, Sievert M, Oppenheim A, Moldawer NP, Knudsen B, Freeman M, Bhowmick N, Rogatko A, Tseng H, Chung LW, et al. A translational phase 2 study of cabozantinib in men with metastatic castration resistant prostate cancer with visceral metastases with characterization of circulating tumor cells and large oncosomes. Journal of Clinical Oncology. 32. DOI: 10.1200/Jco.2014.32.15_Suppl.E16080 |
0.349 |
|
2014 |
Lu Y, Jiang R, Tseng H, Chung LW, Posadas EM. Abstract 938: Single-cell whole-genome sequencing verifies the surrogacy of circulating tumor cells for prostate cancer Cancer Research. 74: 938-938. DOI: 10.1158/1538-7445.Am2014-938 |
0.435 |
|
2014 |
Ankeny JS, Hou S, Lin M, Frias M, OuYang H, Song M, Rochefort MM, Girgis MD, Tseng H, Tomlinson JS. Abstract 3070: Capture, isolation, and mutational analysis of single pancreatic circulating tumor cells using NanoVelcro technology Cancer Research. 74: 3070-3070. DOI: 10.1158/1538-7445.Am2014-3070 |
0.421 |
|
2013 |
Lu YT, Zhao L, Shen Q, Garcia MA, Wu D, Hou S, Song M, Xu X, Ouyang WH, Ouyang WW, Lichterman J, Luo Z, Xuan X, Huang J, Chung LW, ... ... Tseng HR, et al. NanoVelcro Chip for CTC enumeration in prostate cancer patients. Methods (San Diego, Calif.). 64: 144-52. PMID 23816790 DOI: 10.1016/J.Ymeth.2013.06.019 |
0.631 |
|
2013 |
Zhao L, Lu YT, Li F, Wu K, Hou S, Yu J, Shen Q, Wu D, Song M, OuYang WH, Luo Z, Lee T, Fang X, Shao C, Xu X, ... ... Tseng HR, et al. High-purity prostate circulating tumor cell isolation by a polymer nanofiber-embedded microchip for whole exome sequencing. Advanced Materials (Deerfield Beach, Fla.). 25: 2897-902. PMID 23529932 DOI: 10.1002/Adma.201205237 |
0.652 |
|
2013 |
Lee JH, Chen KJ, Noh SH, Garcia MA, Wang H, Lin WY, Jeong H, Kong BJ, Stout DB, Cheon J, Tseng HR. On-demand drug release system for in vivo cancer treatment through self-assembled magnetic nanoparticles. Angewandte Chemie (International Ed. in English). 52: 4384-8. PMID 23519915 DOI: 10.1002/Anie.201207721 |
0.629 |
|
2013 |
Shen Q, Xu L, Zhao L, Wu D, Fan Y, Zhou Y, Ouyang WH, Xu X, Zhang Z, Song M, Lee T, Garcia MA, Xiong B, Hou S, Tseng HR, et al. Specific capture and release of circulating tumor cells using aptamer-modified nanosubstrates. Advanced Materials (Deerfield Beach, Fla.). 25: 2368-73. PMID 23495071 DOI: 10.1002/Adma.201300082 |
0.658 |
|
2013 |
Hou S, Zhao L, Shen Q, Yu J, Ng C, Kong X, Wu D, Song M, Shi X, Xu X, OuYang WH, He R, Zhao XZ, Lee T, Brunicardi FC, ... ... Tseng HR, et al. Polymer nanofiber-embedded microchips for detection, isolation, and molecular analysis of single circulating melanoma cells. Angewandte Chemie (International Ed. in English). 52: 3379-83. PMID 23436302 DOI: 10.1002/Anie.201208452 |
0.664 |
|
2013 |
Hou S, Zhao H, Zhao L, Shen Q, Wei KS, Suh DY, Nakao A, Garcia MA, Song M, Lee T, Xiong B, Luo SC, Tseng HR, Yu HH. Capture and stimulated release of circulating tumor cells on polymer-grafted silicon nanostructures. Advanced Materials (Deerfield Beach, Fla.). 25: 1547-51. PMID 23255101 DOI: 10.1002/Adma.201203185 |
0.673 |
|
2013 |
Hou S, Zhao L, Shen Q, Yu J, Ng C, Kong X, Wu D, Song M, Shi X, Xu X, OuYang W, He R, Zhao X, Lee T, Brunicardi FC, ... ... Tseng H, et al. Inside Back Cover: Polymer Nanofiber-Embedded Microchips for Detection, Isolation, and Molecular Analysis of Single Circulating Melanoma Cells (Angew. Chem. Int. Ed. 12/2013) Angewandte Chemie International Edition. 52: 3533-3533. DOI: 10.1002/Anie.201301082 |
0.596 |
|
2013 |
Hou S, Zhao L, Shen Q, Yu J, Ng C, Kong X, Wu D, Song M, Shi X, Xu X, OuYang W, He R, Zhao X, Lee T, Brunicardi FC, ... ... Tseng H, et al. Innenrücktitelbild: Polymer Nanofiber-Embedded Microchips for Detection, Isolation, and Molecular Analysis of Single Circulating Melanoma Cells (Angew. Chem. 12/2013) Angewandte Chemie. 125: 3619-3619. DOI: 10.1002/Ange.201301082 |
0.597 |
|
2013 |
Zhao L, Lu Y, Li F, Wu K, Hou S, Yu J, Shen Q, Wu D, Song M, OuYang W, Luo Z, Lee T, Fang X, Shao C, Xu X, ... ... Tseng H, et al. Tumor Cell Isolation: High-Purity Prostate Circulating Tumor Cell Isolation by a Polymer Nanofiber-Embedded Microchip for Whole Exome Sequencing (Adv. Mater. 21/2013) Advanced Materials. 25: 2870-2870. DOI: 10.1002/Adma.201370136 |
0.634 |
|
2013 |
Hou S, Zhao H, Zhao L, Shen Q, Wei KS, Suh DY, Nakao A, Garcia MA, Song M, Lee T, Xiong B, Luo S, Tseng H, Yu H. Cell Capture: Capture and Stimulated Release of Circulating Tumor Cells on Polymer-Grafted Silicon Nanostructures (Adv. Mater. 11/2013) Advanced Materials. 25: 1514-1514. DOI: 10.1002/Adma.201370069 |
0.614 |
|
2012 |
Chen KJ, Tang L, Garcia MA, Wang H, Lu H, Lin WY, Hou S, Yin Q, Shen CK, Cheng J, Tseng HR. The therapeutic efficacy of camptothecin-encapsulated supramolecular nanoparticles. Biomaterials. 33: 1162-9. PMID 22074663 DOI: 10.1016/J.Biomaterials.2011.10.044 |
0.66 |
|
2011 |
Sekine J, Luo SC, Wang S, Zhu B, Tseng HR, Yu HH. Functionalized conducting polymer nanodots for enhanced cell capturing: the synergistic effect of capture agents and nanostructures. Advanced Materials (Deerfield Beach, Fla.). 23: 4788-92. PMID 21954025 DOI: 10.1002/Adma.201102151 |
0.301 |
|
2011 |
Wang S, Owens GE, Tseng HR. Nano "fly paper" technology for the capture of circulating tumor cells. Methods in Molecular Biology (Clifton, N.J.). 726: 141-50. PMID 21424448 DOI: 10.1007/978-1-61779-052-2_10 |
0.408 |
|
2011 |
Wang S, Liu K, Liu J, Yu ZT, Xu X, Zhao L, Lee T, Lee EK, Reiss J, Lee YK, Chung LW, Huang J, Rettig M, Seligson D, Duraiswamy KN, ... ... Tseng HR, et al. Highly efficient capture of circulating tumor cells by using nanostructured silicon substrates with integrated chaotic micromixers. Angewandte Chemie (International Ed. in English). 50: 3084-8. PMID 21374764 DOI: 10.1002/Anie.201005853 |
0.46 |
|
2011 |
Liu Y, Wang H, Kamei K, Yan M, Chen KJ, Yuan Q, Shi L, Lu Y, Tseng HR. Delivery of intact transcription factor by using self-assembled supramolecular nanoparticles. Angewandte Chemie (International Ed. in English). 50: 3058-62. PMID 21370360 DOI: 10.1002/Anie.201005740 |
0.521 |
|
2011 |
Chen KJ, Wolahan SM, Wang H, Hsu CH, Chang HW, Durazo A, Hwang LP, Garcia MA, Jiang ZK, Wu L, Lin YY, Tseng HR. A small MRI contrast agent library of gadolinium(III)-encapsulated supramolecular nanoparticles for improved relaxivity and sensitivity. Biomaterials. 32: 2160-5. PMID 21167594 DOI: 10.1016/J.Biomaterials.2010.11.043 |
0.647 |
|
2011 |
Kamei K, Sun J, Tseng HR, Damoiseaux R. Microfluidic image cytometry. Methods in Molecular Biology (Clifton, N.J.). 706: 191-206. PMID 21104065 DOI: 10.1007/978-1-61737-970-3_16 |
0.406 |
|
2011 |
Wang S, Liu K, Liu J, Yu ZT, Xu X, Zhao L, Lee T, Lee EK, Reiss J, Lee Y, Chung LWK, Huang J, Rettig M, Seligson D, Duraiswamy KN, ... ... Tseng H, et al. Cover Picture: Highly Efficient Capture of Circulating Tumor Cells by Using Nanostructured Silicon Substrates with Integrated Chaotic Micromixers (Angew. Chem. Int. Ed. 13/2011) Angewandte Chemie International Edition. 50: 2857-2857. DOI: 10.1002/Anie.201100624 |
0.375 |
|
2011 |
Wang S, Liu K, Liu J, Yu ZT, Xu X, Zhao L, Lee T, Lee EK, Reiss J, Lee Y, Chung LWK, Huang J, Rettig M, Seligson D, Duraiswamy KN, ... ... Tseng H, et al. Titelbild: Highly Efficient Capture of Circulating Tumor Cells by Using Nanostructured Silicon Substrates with Integrated Chaotic Micromixers (Angew. Chem. 13/2011) Angewandte Chemie. 123: 2909-2909. DOI: 10.1002/Ange.201100624 |
0.38 |
|
2010 |
Liu K, Wang H, Chen KJ, Guo F, Lin WY, Chen YC, Phung DL, Tseng HR, Shen CK. A digital microfluidic droplet generator produces self-assembled supramolecular nanoparticles for targeted cell imaging. Nanotechnology. 21: 445603. PMID 20935351 DOI: 10.1088/0957-4484/21/44/445603 |
0.518 |
|
2010 |
Wang H, Liu K, Chen KJ, Lu Y, Wang S, Lin WY, Guo F, Kamei K, Chen YC, Ohashi M, Wang M, Garcia MA, Zhao XZ, Shen CK, Tseng HR. A rapid pathway toward a superb gene delivery system: programming structural and functional diversity into a supramolecular nanoparticle library. Acs Nano. 4: 6235-43. PMID 20925389 DOI: 10.1021/Nn101908E |
0.667 |
|
2010 |
Sun J, Masterman-Smith MD, Graham NA, Jiao J, Mottahedeh J, Laks DR, Ohashi M, DeJesus J, Kamei K, Lee KB, Wang H, Yu ZT, Lu YT, Hou S, Li K, ... ... Tseng HR, et al. A microfluidic platform for systems pathology: multiparameter single-cell signaling measurements of clinical brain tumor specimens. Cancer Research. 70: 6128-38. PMID 20631065 DOI: 10.1158/0008-5472.Can-10-0076 |
0.398 |
|
2010 |
Wang S, Chen KJ, Wu TH, Wang H, Lin WY, Ohashi M, Chiou PY, Tseng HR. Photothermal effects of supramolecularly assembled gold nanoparticles for the targeted treatment of cancer cells. Angewandte Chemie (International Ed. in English). 49: 3777-81. PMID 20391446 DOI: 10.1002/Anie.201000062 |
0.525 |
|
2010 |
Kamei K, Ohashi M, Gschweng E, Ho Q, Suh J, Tang J, For Yu ZT, Clark AT, Pyle AD, Teitell MA, Lee KB, Witte ON, Tseng HR. Microfluidic image cytometry for quantitative single-cell profiling of human pluripotent stem cells in chemically defined conditions. Lab On a Chip. 10: 1113-9. PMID 20390128 DOI: 10.1039/B922884E |
0.301 |
|
2010 |
Wang H, Chen KJ, Wang S, Ohashi M, Kamei K, Sun J, Ha JH, Liu K, Tseng HR. A small library of DNA-encapsulated supramolecular nanoparticles for targeted gene delivery. Chemical Communications (Cambridge, England). 46: 1851-3. PMID 20198230 DOI: 10.1039/B923711A |
0.503 |
|
2010 |
Jung J, Solanki A, Memoli KA, Kamei K, Kim H, Drahl MA, Williams LJ, Tseng HR, Lee K. Selective inhibition of human brain tumor cells through multifunctional quantum-dot-based siRNA delivery. Angewandte Chemie (International Ed. in English). 49: 103-7. PMID 19950159 DOI: 10.1002/Anie.200905126 |
0.303 |
|
2009 |
Wang S, Wang H, Jiao J, Chen KJ, Owens GE, Kamei K, Sun J, Sherman DJ, Behrenbruch CP, Wu H, Tseng HR. Three-dimensional nanostructured substrates toward efficient capture of circulating tumor cells. Angewandte Chemie (International Ed. in English). 48: 8970-3. PMID 19847834 DOI: 10.1002/Anie.200901668 |
0.596 |
|
2009 |
Wang H, Wang S, Su H, Chen KJ, Armijo AL, Lin WY, Wang Y, Sun J, Kamei K, Czernin J, Radu CG, Tseng HR. A supramolecular approach for preparation of size-controlled nanoparticles. Angewandte Chemie (International Ed. in English). 48: 4344-8. PMID 19425037 DOI: 10.1002/anie.200900063 |
0.426 |
|
2009 |
Yu ZT, Kamei K, Takahashi H, Shu CJ, Wang X, He GW, Silverman R, Radu CG, Witte ON, Lee KB, Tseng HR. Integrated microfluidic devices for combinatorial cell-based assays. Biomedical Microdevices. 11: 547-55. PMID 19130244 DOI: 10.1007/S10544-008-9260-X |
0.343 |
|
2007 |
Sui G, Lee CC, Kamei K, Li HJ, Wang JY, Wang J, Herschman HR, Tseng HR. A microfluidic platform for sequential ligand labeling and cell binding analysis. Biomedical Microdevices. 9: 301-5. PMID 17195108 DOI: 10.1007/S10544-006-9033-3 |
0.316 |
|
1999 |
Tseng H, Lee C, Yang L, Luh T. Umpolung Of Carbon-Sulfur Bonds. Novel Synthesis Of Substituted Allenes From Propargylic Dithioacetals Journal of Organic Chemistry. 64: 8582-8587. DOI: 10.1021/Jo991032B |
0.493 |
|
1997 |
Tseng H, Luh T. Novel Coupling Reactions of Dithioacetals with Organocuprate Reagents. Propargylic Dithioacetal as an Allene−1,3-Zwitterion Synthon Journal of Organic Chemistry. 62: 4568-4569. DOI: 10.1021/Jo970700V |
0.497 |
|
1996 |
Tseng H, Luh T. Propargylic Dithioacetal as an Allene 1,3-Dication Synthon. Nickel-Catalyzed Cross-Coupling Reactions of Propargylic Dithioacetals with Grignard Reagents† Journal of Organic Chemistry. 61: 8685-8686. DOI: 10.1021/Jo961514C |
0.488 |
|
Show low-probability matches. |